Want to see DNA full AI Analyst Report?
Operating Expense Breakdown
Details core costs like R&D, marketing, and admin, offering insight into how efficiently the company runs and where it’s prioritizing investment.After large, likely non‑recurring spikes in late 2021/early 2022, Ginkgo has driven both R&D and G&A sharply lower and into a much lower, steadier quarterly run‑rate—a clear company‑wide cost reset. That reduces cash burn and dilution risk and improves near‑term runway, but the sustained R&D cuts create execution risk for long‑term product/platform development; modest upticks in late‑2025 could signal selective reinvestment if revenue momentum justifies it.
Date | Research & Development | General & Administrative |
|---|---|---|
Jun 30, 2026 | $46.21M | $30.77M |
Mar 31, 2026 | $49.92M | $37.83M |
Dec 31, 2025 | $50.13M | $46.01M |
Sep 30, 2025 | $69.35M | $44.95M |
Jun 30, 2025 | $53.37M | $43.28M |
Mar 31, 2025 | $70.92M | $49.04M |
Dec 31, 2024 | $76.38M | $57.30M |
Sep 30, 2024 | $77.01M | $52.29M |
Jun 30, 2024 | $134.22M | $66.28M |
Mar 31, 2024 | $136.46M | $70.29M |